Open AccessP1017: HARBOR: A PHASE 2/3 STUDY OF BLU‐263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
Author(s) -
Castells M.,
Scherber R.,
Bhavsar V.,
He K.,
Akin C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846936.51452.f2
Subject(s) - systemic mastocytosis , mast cell , medicine , monoclonal , dosing , placebo , cutaneous mastocytosis , monoclonal antibody , pharmacology , immunology , pathology , antibody , alternative medicine